Cited 0 times in
A plain language summary of the results from the group of patients in the CHRYSALIS study with EGFR exon 20 insertion-mutated non-small-cell lung cancer who received amivantamab
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.